Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Molecular Mechanisms

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health issue characterized by persistent airflow limitation and inflammation.
• The precise cellular mechanisms driving COPD pathogenesis, particularly involving cell death, are not fully understood.
• Regulated cell death (RCD) encompasses diverse pathways beyond apoptosis, including necroptosis, pyroptosis, ferroptosis, and others.

Purpose of the Study:

• To review the molecular mechanisms through which various RCD pathways contribute to COPD onset and progression.
• To explore the therapeutic potential of targeting RCD pathways for COPD treatment.
• To enhance understanding of COPD pathophysiology and identify novel therapeutic strategies.

Main Methods:

• Literature review synthesizing current research on RCD pathways in COPD.
• Analysis of molecular mechanisms linking specific RCD types to COPD pathogenesis.
• Evaluation of preclinical and clinical evidence for RCD-targeting agents in COPD.

Main Results:

• Growing evidence suggests RCD pathways play significant roles in COPD development and progression.
• Specific RCD pathways like necroptosis, pyroptosis, and ferroptosis are implicated in airway inflammation and remodeling.
• Agents targeting RCD pathways demonstrate potential therapeutic benefits in preclinical COPD models.

Conclusions:

• Regulated cell death pathways are critical mediators in COPD.
• Targeting RCD pathways represents a promising avenue for novel COPD therapeutics.
• Further research into RCD mechanisms can unlock innovative treatment strategies for COPD.